<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02704312</url>
  </required_header>
  <id_info>
    <org_study_id>15/ B/ 25</org_study_id>
    <nct_id>NCT02704312</nct_id>
  </id_info>
  <brief_title>Dosimetric Comparison of Doses in Both Positions (Prone and Decubitus) for Patient With Breast Cancer</brief_title>
  <acronym>PROCUBITUS</acronym>
  <official_title>A Feasibility Study of Patient Comfort and Dosimetry Evaluation in Prone Breast Radiotherapy.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Center of Martinique</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital Center of Martinique</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Compare dosimeters in both positions (prone and decubitus) for each patient&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Quantitative Physics: dosimetric comparison of doses in target volumes and organs at risk.&#xD;
      The technique used is that of which the dose on the organs at risk is as low as possible, and&#xD;
      whose dose to the target volume is the closest possible to the prescribed dose (100% of the&#xD;
      prescribed dose).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">November 30, 2015</start_date>
  <completion_date type="Anticipated">December 2022</completion_date>
  <primary_completion_date type="Anticipated">August 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Quantitative Physics: dosimetric comparison of doses in target volumes and organs at risk</measure>
    <time_frame>From baseline to 5 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of Life Questionnaire</measure>
    <time_frame>Baseline and Follow up month 3, 12, 24 and 36</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">37</enrollment>
  <condition>Breast Cancer</condition>
  <arm_group>
    <arm_group_label>Radiotherapy techniques</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Quantitative Physics: dosimetric comparison of doses in target volumes and organs at risk. The technique used is that of which the dose on the organs at risk is as low as possible, and whose dose to the target volume is the closest possible to the prescribed dose (100% of the prescribed dose)</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Radiotherapy by Prone and decubitus</intervention_name>
    <description>Dosimetric comparison of doses in target volumes and organs at risk</description>
    <arm_group_label>Radiotherapy techniques</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients with primary breast cancer and in whom conservative post- surgery radiation&#xD;
             therapy for breast cancer is prescribed.&#xD;
&#xD;
          -  Patients aged over 18 years&#xD;
&#xD;
          -  Patients with indication for conservative surgery.&#xD;
&#xD;
          -  Resection should be in healthy margin.&#xD;
&#xD;
          -  Women of childbearing potential must satisfy a negative pregnancy test at the&#xD;
             screening visit and use effective contraception as determined by the physician of the&#xD;
             patient throughout the study.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Minor Patient&#xD;
&#xD;
          -  Patients whose tumor resection is incomplete&#xD;
&#xD;
          -  Patients with an indication of mastectomy&#xD;
&#xD;
          -  Patients with a history of radiation therapy of the chest&#xD;
&#xD;
          -  Pregnant women, lactating, or of childbearing age without effective contraception.&#xD;
&#xD;
          -  Patients who had more than 4 scanners in one year. ( Scanner cervical , thoracic, or&#xD;
             abdominal&#xD;
&#xD;
          -  Patients with an incompatible condition with monitoring protocol (psychiatric&#xD;
             disorder, uncontrolled disease).&#xD;
&#xD;
          -  Patient unable to respond to a questionnaire&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vincent VINH HUNG, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU de Martinique</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CHU de Martinique</name>
      <address>
        <city>Fort de France</city>
        <country>Martinique</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Martinique</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>March 1, 2016</study_first_submitted>
  <study_first_submitted_qc>March 4, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 10, 2016</study_first_posted>
  <last_update_submitted>February 9, 2021</last_update_submitted>
  <last_update_submitted_qc>February 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 10, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

